Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

MIXED(1)
1 unique interventions1 categories

Analytics

Trial Phases

Phase 41

Trial Status

Completed1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT00520494Phase 4Completed
Efficacy and Safety of Vivaglobin® in Previously Untreated Patients With Primary Immunodeficiency
AgammaglobulinemiaCommon Variable Immunodeficiency
Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Klinik für Kinder-und Jugendmedizin am Städtischen Klinikum St. Georg, Leipzig, Germany

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Albertina RB Pizzamiglio, md MSc

Federal University of São Paulo

Moderately Similar
1 trials

Shared therapeutic areas:

AgammaglobulinemiaCommon Variable Immunodeficiency

Worked with same sponsors:

CSL Behring
Similarity Score30%

Program Director

CSL Behring

Moderately Similar
12 trials

Shared therapeutic areas:

AgammaglobulinemiaCommon Variable Immunodeficiency

Worked with same sponsors:

CSL Behring
Similarity Score30%

Erwin Gelfand, MD

National Jewish Medical and Research Center, Denver, CO

Moderately Similar
1 trials

Shared therapeutic areas:

AgammaglobulinemiaCommon Variable Immunodeficiency
Similarity Score30%

Beatriz T Costa Carvalho, md PhD

Federal University of São Paulo

Moderately Similar
1 trials

Shared therapeutic areas:

AgammaglobulinemiaCommon Variable Immunodeficiency

Worked with same sponsors:

CSL Behring
Similarity Score30%

Charles K Naspitz, md MSc

Federal University of São Paulo

Moderately Similar
1 trials

Shared therapeutic areas:

AgammaglobulinemiaCommon Variable Immunodeficiency

Worked with same sponsors:

CSL Behring
Similarity Score30%

Aparecida T Nagao-Dias

Federal University of Ceará

Moderately Similar
1 trials

Shared therapeutic areas:

AgammaglobulinemiaCommon Variable Immunodeficiency

Worked with same sponsors:

CSL Behring
Similarity Score30%

Kevin P Fennelly, M.D.

National Heart, Lung, and Blood Institute (NHLBI)

Related
2 trials

Shared therapeutic areas:

Common Variable Immunodeficiency
Similarity Score15%

John Sleasman, MD

Duke University

Related
2 trials

Shared therapeutic areas:

Common Variable Immunodeficiency
Similarity Score15%

Dewton Moraes Vasconcelos, PhD

Hospital do Coracao

Related
1 trials

Shared therapeutic areas:

Agammaglobulinemia
Similarity Score15%

Sung-Yun Pai, M.D.

National Cancer Institute (NCI)

Related
2 trials

Shared therapeutic areas:

Common Variable Immunodeficiency
Similarity Score15%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT00520494Phase 4PrincipalInvestigator

Efficacy and Safety of Vivaglobin® in Previously Untreated Patients With Primary Immunodeficiency

AgammaglobulinemiaCommon Variable Immunodeficiency
Completed

All 1 trials loaded